| Bioactivity | Tezepelumab (anti-TSLP) is human monoclonal antibody (IgG2λ) that binds specifically to TSLP, blocking it from interacting with its heterodimeric receptor. Tezepelumab can be used for the research of severe, uncontrolled asthma[1]. |
| Invitro | Tezepelumab (anti-TSLP) 阻断胸腺基质淋巴细胞生成素，一种上皮细胞衍生的细胞因子，与哮喘的发病机理有关[1]。 MCE has not independently confirmed the accuracy of these methods. They are for reference only. 0 --> Tezepelumab (anti-TSLP) 相关抗体: |
| CAS | 1572943-04-4 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Menzies-Gow A, et, al. Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma. N Engl J Med. 2021 May 13;384(19):1800-1809. |